HealthEconomics.Com - The Resource for Health Outcomes Professionals

search   
Sign Up For Our Newsletter
Email:  


industry news

From NCE to NICE: the role of Pharmacoeconomics

What Is the Price Benchmark to Replace Average Wholesale Price (AWP)?

NICE announces development of further Quality Standards

Avastin patient access scheme too complicated, says NICE

Comparative Effectiveness—of What? Evaluating Strategies to Improve Population Health

Market access and patient access schemes

Market access: Risk sharing and alternative pricing schemes

US breast cancer drug decision 'marks start of death panels'

Medical Affairs at the centre of life sciences innovation

Rising Burden of Diseases Drives the Pharmaceutical Industry in East Africa Says Frost & Sullivan

Is Health Care Special?

CRD international register of ongoing systematic reviews

Hospitals Should Plan Now for Value-Based Purchasing, Which May Be a Game-Changer

Comparative Effectiveness Research

Health care and revenue competition in Britain

Literature Review Examines Value of Managed Care Pharmacy Tools

Compelling Evidence Regarding Effectiveness Of Managed Care Pharmacy Tools In Achieving Intended Outcomes

IBM, Aetna roll out cloud-based clinical decision support system

Health Economics Spending Increases 45% in Emerging Markets, 8% in the US

Health Secretary Andrew Lansley announces new NHS ‘quality standards’

PharmaNet, Abacus ally on ‘real world' research

The Impact of Employer Health and Productivity Management Practices

NICE ‘yes’ in 80% of treatment appraisals

Providers Have Won Majority of RAC Claims Denials They Have Appealed

Study examines UK’s NICE as model producer of HTA

Health Secretary Andrew Lansley announces new NHS ‘quality standards’

Government kicks off consultation on outcomes framework

Will More Insurers Control Health Care Costs Better?

Will Janssen-Cilag's ADHD YouTube Video Go Viral and Win an Award?

Reimbursement by Distributors

Growing application of pharmacoeconomics and outcomes research in health-care decision-making in the Asia-Pacific region.Yang BM, Lee K. Value Health. 2009 Nov-Dec;12 Suppl 3:S1-2.

Value-based Pricing to be Introduced to the UK Pharma Industry by 2014

Disclosing Industry Relationships — Toward an Improved Federal Research Policy

Pharmacoeconomics: friend or foe?

NHS reform – a bold vision or a dangerous gamble?

GSK's Coverup of Avandia's Heart Risk Data: Is This How the Entire Industry Views Its Repsonsibility to Patients?

Oncology drug price cuts announced in Italy related to perfomance based schemes

US And European Prices Aren’t So Different After All

Grand challenges in pharmacoeconomics and health outcomes

White Paper: An Economic Assessment of the Relationship between Price Regulation and Incentives to Innovate in the Pharmaceutical Industry

Clarifying Sources of Geographic Differences in Medicare Spending

Is The Impact of Comparative Effectiveness Reports Being Evaluated? by Rebecca Singer Cohen Rebecca Singer Cohen View Author Bio and Bryan Luce

Biosimilars’ Price Dynamic in Europe, Dr Matthias Liefner of Simon Kucher and Partners.

AQoL Website - Centre for Health Economics, Monash University

“How To Negotiate Salary”, a submitted article by Bill Cebak - Founder / Headhunter Global HEOR, Market Access and Medical Communications Practice since 1993

AMCP eDossier System: A Partnership that Works! AMCP News June 2010

Dartmouth Atlas: A Response to Its Researchers

D2 Review : APHA and AMCP introduce MTM Connections a fantastic site for new professional opportunities

Including Pregnant Women in Clinical Research Called ‘Imperative’

Selecting Quality and Resource Use Measures A Decision Guide for Community Quality Collaboratives

Spending More on Drugs Doesn’t Mean Spending Less On Other Care

Trendspotter: Consumer Survey Shows Opposition to Evidence-Based Medicine

Patient Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Former CMS Official’s Off-Label Work May Help Reform Law’s CER Center

Patient-reported outcome measures in the NHS: new methods for analysing and reporting EQ-5D data

Integrated Health Ecosystem Key to Creating Better Health Outcomes and Managing Costs for Employers and Health Plans

The Health Care Economy: New Questions About Costs, Quality And Care

The Amazing Maze of US Health Care

Universal Healthcare Myths | New Health Care Bill Facts

Pricing, profits and pharmacoeconomics - for whose benefit?

Symposium on Research Methods for Clinical and Comparative Effectiveness Studies – Part II

France, Italy announce drug pricing cuts

"AMCP Launches Health Care Reform Implementation Web Page"

2010 Lecture: US Health Care Reform

Biosimilars: Issues Overview

AZ's fixed-price deal on Iressa gets NICE nod

Transforming Trial Results Into Practice Change: The Final Translational Hurdle

Obama’s New Health Rationer-in-Chief

NICE to move to value-based pricing?

Reimbursement of New High Cost Drugs – Deal or No Deal! by:Michael Barry MD, PhD, FRCPI, 2009-2010 ISPOR President and Clinical Director National Centre for Pharmacoeconomics, St. James’s Hospital, Dublin, Ireland

UK Government Wants To Revamp Drug Watch Dog NICE

New FDA Campaign Targets Detailing, Trade Shows

Advances in technology highlight need of Pharmacoeconomics in managing healthcare: Dr Rajesh Balakrishnan

RFP for 2011 IBI/NBCH Health & Productivity Forum

Funny Pharmacy Videos. These are Hysterical! Particularly "The PharmG's - Boom Intervention" Rap

hot jobs

Job Title Company
Program Director, Applied Health Economics and Outcomes Research Jefferson School of Population Health
Senior and Principal Consultants Bridgehead International Limited
Research Scientist/Senior Research Associate – Literature Review and Meta-Analytic Services (London, UK) United BioSource Corporation
DIRECTOR, HEALTH ECONOMICS & MARKET ACCESS Medaxial
Assistant or Associate Professor of Outcomes Sciences SC College of Pharmacy


miscellaneous

$232 Billion Personalized Medicine Market to Grow 11 Percent Annually, says PricewaterhouseCoopers
Personalize medicine, which targets individualized treatment and care based on personal and genetic variation, is creating a booming market, but it is a disruptive innovation that PricewaterhouseCoopers says will create both opportunities and challenges for traditional healthcare and emerging market participants. (Source: PR Newswire, New York, Dec. 8, 2009)
A Taxonomy for the Design, Development & Implementation of Patient Registries
Absence of evidence Vs Evidence of absence
Thought-provoking article suggesting that evidence-based medicine today has become evidence burdened instead. (Source: Hegde, Mangalorean.com, Nov. 2009)
Academy of Managed Care Pharmacy (AMCP)
YouTube Video where Academy of Managed Care Pharmacy (AMCP) discusses issues that health plans need to consider to prepare for the eventual arrival of follow-on biologics.
AHRQ Registries for Evaluating Patient Outcomes
Comments on the draft handbook from UBC (United Biosource Corp).
Alegent Health P4P
Discusses recent initiative by employer to return money to employees for improving health. Demonstrates a pay for performance (P4P) initiative and an employer who is interested in indirect and direct medical cost management.
AMA Physician Select
From AMA, this is an on-line "doctor finder" providing information on virtually every licensed physician in the US.
Analysis of Effectiveness and Cost Effectiveness in Patient Registries
Asia Pacific Biotechnology Market (2008-2012): An Exhaustive View of the Biotechnology Markets in the Asia-Pacific Region
The report "Asia Pacific Biotechnology Market (2008-2012)" provides an exhaustive view of the biotechnology markets in the Asia-Pacific region. (Source: Gale, Cengage Learning, Business Wire, 2008)
Assurance Pharmaceutical Care Documentation Software
Assurance Pharmaceutical Care™ is a computer-based documentation system designed to support the practice of pharmaceutical care. This program is used by pharmaceutical care practitioners to manage all of a patient's medications and to document outcomes from drug therapies, cost savings, and clinical improvement in patient care. It supports all reimbursement methods and practitioners providing medication therapy management (MTM) services to patients on a continuous basis, over repeated patient encounters, at multiple practice sites, by multiple practitioners, and it is fully developed to support an entire network of practitioners.
Balancing Innovation, Access, and Profits — Market Exclusivity for Biologics
Balancing Innovation, Access, and Profits — Market Exclusivity for Biologics. (Source: Alfred B. Engelberg, J.D., Aaron S. Kesselheim, M.D., J.D., M.P.H., and Jerry Avorn, M.D., NEJM, October 2009)
Barriers to Generalizability of Health Economic Evaluations in Latin America and the Caribbean Region
Barriers to Generalizability of Health Economic Evaluations in Latin America and the Caribbean Region. (Source: PharmacoEconomics: 1 November 2009 - Volume 27 - Issue 11 - pp 919-929)
Bayesian Statistics for Health Economics and Outcomes Research by O
Wonderful primer that makes the subject of bayesian statistics understandable, relevant, and interesting.
Bending the Curve: Options for Achieving Savings and Improving in U.S. Health Spending
This article summarizies findings of a report funded by The Commonwealth Fund Commission on a High Performance Health System. 15 federal policy options and their potential for lowering health spending are examined. (Source: Brian Ahier, Health IT & Healthcare Reform, Nov 21, 2009)
Best Practices in Biotechnology Business Development
By Yali Friedman. Valuation, Licensing, Cash Flow, Pharmacoeconomics, Market Selection, Communication, and Intellectual Property
Bias, Credibility and Quality in Economic Evaluations
Advisory Panel Report from ISPOR
BioSnail
Job interview techniques, sample resumes, job search strategy, free resume design, etc.
Blog: Akshay G. Kapur Discussing healthcare, business intelligence, books, and ideas
Discussion of P4P, QALY, health economics, and other information.
Blog: Health Equity Blogspot
Blog: Piper Report
Popular health care blog. Medicare, Medicaid, pharma, reform, and more. Insights and resources on hot issues. Kip Piper, editor.
Budget Impact Analysis
Comments from United Biosource Corp. on ISPOR guidelines for Budget Impact Analysis
CBO June 16, 2009 Report on Health Care Reform
Health Care Reform and the Federal Budget
CEA Data Sources
Links to: *Data on the cost of medical goods and services. *Data used to calculate ambulatory care, hospitalization, and mortality rates. *Incidence and prevalence of diseases. *Health-Related Quality of Life (HRQL). *Sites that provide access to multiple datasets. *Population Data (US Bureau of the Census)
Center for Health Economics (CHE) newsletter
Articles such as: methodological research priority development for NICE, geographical variation in QOL, NHS productivity growth, conferences, and publications.
Clinical Trial Recruitment Strategy
Enables clinical trial administrators to identify investigators and recruit patients more quickly and efficiently by applying objective, evidenced-based metrics to site selection and patient recruitment.
Cluster randomization in Health Outcomes Research
A PPT presentation, "Cluster randomization in Health Outcomes Research", is 59 charts in length. (Source: Institue for Health Research, August 2009)
Comparative Effectiveness Funding Report
The report to the President and Congress for how the HHS Office of the Secretary should spend $400 million in funding for patient-centered research (comparative effectiveness research) was released at the end of June.
Conferences from The Center for Business Intelligence
Dedicated to developing market-driven, unbiased conferences in pharmaceuticals\biotech, medical devices, risk and insurance and managed care markets. Continuous cycle of relevant conferences.
Consumer Directed Health Plans Research Report
The Consumer-Directed Health Market: Implications of New Benefit Designs by The Zitter Group
Consumer Price Index
CPI database, inflation calculator, etc.
Consumer Reports Health: Drug Effectiveness Review Project
Consumer Reports publication "Best Buy Drugs (or Best Drugs For Less)" which rates 200 Rx and OTC drugs on efficacy and cost, using an "unbiased review of the best scientific evidence available". They work closely with experts at Drug Effectiveness Review Project, part of the Oregon Health and Science University in Portland.
Consumer Reports Opinion Poll: 66 of Americans Blindsides by Cost of Drugs
Consumer Reports opinion poll found that only 4% of respondents had discussed drug price with their physician at point of prescribing; 66% "blindsided" by costs once they reached the pharmacy.
Cost effectiveness thresholds
Information on the threshold values used in CHOICE analyses for the relative CE of an intervention in current international dollars of 2000 for 14 countries. Following the recommendations of the Commission on Macroeconomics and Health, CHOICE uses gross domestic product (GDP) as a readily available indicator to derive the following three categories of cost-effectiveness: Highly cost-effective (less than GDP per capita); Cost-effective (between one and three times GDP per capita); and Not cost-effective (more than three times GDP per capita)
Cost Savings From Health IT: Priceless
A new study suggests that the vaunted savings from computerizing Americans' health information will essentially be nonexistent. (Source: Emily Badger, Miller-McCune, Nov. 23, 2009)
Curriculum for Health Economics
A wonderful compilation of books, journals, articles, websites, databases, etc. that you would need if you are new to health economics. In fact, it's a great list if you are an experienced health economist. It only goes up to 2003 but it provides a wonderful, exhaustive overview of relevant resources. Great for students and for teachers preparing courses.
'Dar he Blogs
Another health economic blog by an MD pursuing a PhD in Health Economics from Yale.
Data Management & Analysis Working Group's article, Analysis of Effectiveness in Patient Registry Data is published in the Policy Analysis section of the June issue of ISPOR CONNECTIONS.
Data Probe
Investigative data analysis and decision support system, which runs on Microsoft® Windows workstations and servers, used to manage and analyze large volumes of detailed health data.
Data/Trends from Managed Care Digest
Very interesting, rich site: Click on the different tabs for access to market overview slides by therapeutic area, HMO industry overview, prescription drug costs, etc.
Decision Modelling for Health Economic Evaluation
Book by Andrew Briggs, Karl Claxton, and Mark Sculpher * A practical guide designed to encourage the reader to apply the modelling methods discussed * Provides a step by step guide on how to set up a model, enter the data, analyse the results, and take this forward for future research * Supporting material provided online, including exercise templates and solution files * Relevant to any researchers and analysts responsible for producing or interpreting cost-effectiveness models
Defending Brand Revenue
PDF or buy report. Developing lifecycle management strategies to maximize branded drugs’ profitability is a key strategy for the pharmaceutical industry. Aside from defending against generic competition, lifecycle management strategies enable companies to sustain their revenue streams and fill gaps in their pipelines as increasing numbers of key brands begin to lose patent protection.
Definition of Health Economics
Wikipedia listing. Needs input. Also help create a Wikipedia "health outcomes" listing. There isn't one! Email patti@healtheconomics.com if you want to work together to do this.
Designing and Conducting Cost-Effectiveness Analyses
GREAT SITE: Open courseware on CEA, tutorials of Markov models, QALE calculator, etc.
Determinants of health economic decisions
Summary of presentation by Dr. Daniel Kahneman at 2007 ISPOR meeting. Covers the value of QALY
Developing Nations Special Issue
This includes HTA, CEA, and discussion of barriers for Asia as a whole, Thailand, Taiwan, Uganda, Latin America and Caribbean, and low- and middle-income countries. (Source: Pharmaeconomics, Nov. 1. 2009)
Diabetes Health Economics Resources
Compiled by Thomas Songer, University of Pittsburg. The compilations of papers, cost estimates, and studies vary in their timeliness.
Digital spend: the chicken or the egg?
It is very difficult to get good data on this in the pharma industry. In a recent survey, Cegedim Dendrite mentioned that less than 0.1% of the S&M spend was devoted to digital in 2009 in Europe; in a recent US survey by the same company, the number was estimated to be close to 10% for some of the leading companies.
Directory of Healthcare Recruiters and Search Firms
Listing of hundreds of recruiters and headhunters with names, firms, postal, phone, fax, web and e-mail addresses. Time-saver for job hunters.
Directory of Physician Groups & Networks
Online directory of IPAs, medical group practices, PHOs, practice management companies and management service organizations. Official directory of the IPA Association of America, published by Dorland Healthcare Information.
Direct-to-consumer communication by pharmaceutical companies ? Europeans deserve better - Supporting the right choice in health information
The proposals are continuing to move through the political process in the Parliament. In this context, a group of 29 organizations released 5 recommendation to protect public health and prevent DTC advertising. (Source: European Public Health Alliance, March 15, 2010)
Discussion Lists on Evidence Based Medicine: How to join
WWW directory page on Evidence-based Health related discussion lists. Helps the busy professional learn how to sign up for the proliferation of email discussion lists. Each entry has the name of the list, the joining instructions and a description of its purpose together with any entry criteria.
Disease Incidence Model
For each population, the Disease Incidence Model™ produces a report showing the overall incidence of disease compared to the national norm and quantifying the cost impact of each disease on a per member per month basis and in total. Reports identify diseases that are over-represented and under-represented in the population in terms of frequency and in terms of cost. Reports also depict differences in population demographics driving these variances.
Disease Management ROI: Benchmarks, Metrics, and Case Studies for Success
Join the Managed Care Information Center and experts on disease management analysis for a discussion about disease management and ROI in this special 90-minute audio conference which took place in May 2007 with Ron Z. Goetzel, Ph.D. Director, Cornell Institute for Health and Productivity Studies, Matthew McGinnis,Sr. Director, Ctr for Health Research, Healthways, and Thomas W. Wilson, Ph.D. Epidemiologist Trajectory HealthCare. Cost is $247 for CD + materials
Do Politicians Really Listen to Health Economists? Observations from Europe
ISPOR Connections discusses perspectives on the use and value of health economics from a governmental perspective from the UK, Germany, Sweden, Spain, The Netherlands. (Source: Mittendorf, ISPOR Connections, Nov/Dec. 2009, p.15)
Economic Analysis Worksheet to evaluate journal article
Critical Appraisal worksheet for economic analysis journal article.
Economic Evaluation in Clinical Trials
Book by Henry A Glick, Jalpa A Doshi, Seema S Sonnad, and Daniel Polsky.* Hugely important for anyone involved in the development of new drugs, therapies, or devices * Supporting material provided online * A practical guide to teach the reader how to design and conduct appropriate, rigorous economic evaluations of clinical trials
Ecosante : a site devoted to Health Economics
French meta-site devoted to Health Economics in a broad sense. Links and documents (online and downloadable) are available.
E-Doc Medical Information for South Africa
On line daily news with special areas devoted to medical, nursing, pharmaceutical companies, consumers, etc.
Employer Survey on Health and Productivity Impact
2007 Survey by Hewitt Associates (Summary in Newsletter)
Employer Trends - 2006
Employer Market Intelligence. Click here to see how to obtain updated reports from the Benfield Group.
EMR Software
Electronic medical record & practice management software
EMR Software for Electronic Medical Records
ENDOTALK
Meta-site central location for comprehensive information regarding the specialty of gastrointestinal and surgical endoscopy.
Evidence of Value Model
Performs customized calculations of the value of new drugs, medical devices and other therapeutic interventions. The Model links cost and utilization data from large patient care databases to published clinical data specific to new drugs, classes of drugs, diagnostics, medical technologies, or a combination of drugs and technologies used to treat a specific disease.
Evidence-based Medicine: meta site
WOW and Great Site! Comprehensive site with links to resources for evidence-based medicine. Click on L"ibrary": Many links to articles on how to evaluate. "Organizations" link is full of great information. "Questionnaires" link provides evidence-based medicine evaluation tools.
ExtendMed
Manage medical web conferences. Online event management, complete customization of website to match educational initiative, evaluations, marketing/reg support, summary reports, AV production and logistics coordination
FDA Code of Federal Regulations
The Code of Federal Regulations (CFR) is a codification of the general and permanent rules published in the Federal Register by the Executive departments and agencies of the Federal Government.
Financial Modeler
From Thomson Medstat; helps you easily and confidently forecast future expenditures, establish a budget, and track against that budget throughout the year. It also supports the annual premium and contribution rate-setting process. spacer
Finding and Using Health Statistics: A Self Study Course** - National Information Center on Health Services Research & Health Care Technology (NICHSR)
A very useful interactive tutorial.
first PR SIG workshop was presented at the 11th Annual European Congress in Athens: Use of Real World Data: Challenges in the Analysis of Patient Registry Data
Forecasting Model from Alliance
Improved forecast quality through ’deep strategy’ brought on by dynamic scenario planning, the best way to understand and control corporate risks
Forum: Patient Registry Classification, Design, Operations, Data Analysis, Reporting & Publishing: Putting All the Pieces Together
Click to see presentation.
Gain Power Through Evidence-based Selling
New report from Pharmavoice.com (c): "Gaining Power Through Evidence-Based Selling". Adding evidence-based medicine information to the sales call can increase the value of the sales reps' role and help drive physician prescribing behavior. Learn how to create a successful service model, make the rep essential in today's environment, and learn a new go-to-market strategy.
Gaining Power Through Evidence-Based Selling
Report copyrighted from PharmaVoice; Sales reps need an edge to get face time with physicians. By adding evidence-based medicine information to the sales call increases the sales rep's role.
Getting It Right: Designing Outcomes-Based Physician Incentive Compensation
Is there a "right way" to get physician buy-in of pay-for-performance (P4P)? What makes for an effective outcomes-based incentive program? Listen to this executive-level teleconference on CD-ROM. This special program was sponsored by Managed Care Information Center. This conference was held on July 28, 2005. Cost $149 for CD + materials
Global Biotech Market Analysis and Forecasts, 2008-2023
Paid Report (but a sample is downloadable for free): Global Biotech Market Analysis and Forecasts, 2008-2023, from Visiongain.com. This report covers both the top ten therapy classes as well as the top ten leading pharmaceutical products in the biotech market in particular, as well as leading pipeline agents. Includes forecasting, SWOT analysis, R&D assessments, qualitative evaluations.
Glossary of terms in health economics
From a self-study course developed by the National Information Center on Health Services Research and Health Care Technology (NICHSR). Other modules include scope of appraisal, resources, identification and retrieval, critical appraisal/analysis.
Glossary of Terms on Health Economics and Pharmacoeconomics - maintained by the University of Groningen, the Netherlands
HealthEconomics.nl is an open collaboration and aims to provide a free, comprehensible and open knowledgebase for Health Economics and Pharmacoeconomics. Its main purpose is to provide background information on economic evaluations of healthcare interventions (such as cost-effectiveness analysis and cost-utility analysis) to policy- and decision makers, students, researchers and healthcare workers in the field of healthcare, as well as the general public.
Has the influence of managed care waned? Evidence from the market for physician services
Based on data from the Community Tracking Study, the authors found that MCOs were becoming less restrictive over time in terms of limiting provider services, and were more like non-managed care organizations. (Source: International Journal of Health Care Finance and Economics, March 2010)
HCUP data: direct access
This will take you directly to the data you want.
he P4P Potential: Overcoming the Challenges and Recognizing the Opportunities
The Managed Care Information Center editorial team analyzed the growth and adoption of healthcare provider – physician and hospital – pay-for-performance programs around the country
Health Affairs Blog
Health Economics - Places To Go
A good list of resources available on the web, compiled by a health economic researcher from Germany.
Health Economics Knowledge at Wharton
Newsletter and blogspot on issues in health economics, pharmacoeconomics, outcomes research, health care costs, etc.
Health Forum
Publishes books, other communications, information, education and research products and services that advance leadership for health.
Health INFLATION.com
Monthly update of medical care inflation. Use for pricing policy, negotiating contracts, monitoring trends, forecasting
Health Insurance Reform and Breast Cancer: Making the health care system work for women
This report discusses the various problems with the current health care system for women who have breast cancer, and what solutions will be found through health care reform.
Health Plan Wellness and Health Improvement Programs: What’s Working Today to Achieve Member Commitment and Participation
Discover what’s working in health plan wellness and health promotion programs, award winning and unique programs, best practices, ROI, and lessons learned in this special audio conference, “Winning Ideas in Health Plan Wellness and Health Improvement Programs: What’s Working Today to Achieve Member Commitment and Participation.” The program was held Tuesday, November 15, 2005.
Health plans operate on slim margins
Erin Hoefligner, of Anthem Blue Cross / Blue Sheild -- Ohio, presents the case that insurance profits are slim and insurers should not be the target for reductions to national health care spending. (Source: Erin Hoeflinger, Cincinnati.com, Nov. 22, 2009)
Health Service Journal: Unneeded surgery may be costing the NHS millions
Is unneeded surgery costing NHS millions? The Health Service Journal of the UK says "yes". Patient-reported outcome measures (PROMs) are required and public hospital ratings based on PROMs available by November 2009.
Health Services Research Resources – Leonard Davis Institute, University of PA
Links to associations and alliances, foundations and organizations, research and policy groups.
Health Systems in Transition (HiT) profiles
HiT profiles seek to provide relevant information to support policy-makers and analysts in the development of health systems in Europe. They are building blocks that can be used: * to learn in detail about different approaches to the organization, financing and delivery of health services and the role of the main actors in health systems;* to describe the institutional framework, the process, content and implementation of health care reform programmes; * to highlight challenges and areas that require more in-depth analysis; and * to provide a tool for the dissemination of information on health systems and the exchange of experiences of reform strategies between policy-makers and analysts in different countries.
Healthcare 411
"Healthcare 411" is a new series produced by AHRQ with podcasts and other information to assist consumers with taking charge of the quality of their healthcare. Are you working with AHRQ on these informational pieces? Copyright Healthcare 411. U.S. Agency for Healthcare Research and Quality. Rockville, MD
Healthcare Industry News: New Study Of Physicians Using HIT In Hospitals
"When physicians in hospitals use health information technology (HIT) to its full potential there are fewer deaths, fewer complications, and lower healthcare costs, according to a study supported by the Commonwealth Fund. "
Healthcare Trends & Forecasts in 2008: Performance Expectations for the Healthcare Industry
4 key thought leaders' predictions. Cost is $117
HealthEconomist.biz
HealthEconomist.biz is a blog concerned with the analysis of current issues in health and health care from an economic perspective. It provides authoritative insight and opinion on all topics in health economics, with particular emphasis on international comparisons, the economic evaluation of health technologies and the valuation of health.
Health-Nexus
Health information site that offers links to sites in all categories of health.
HEDIS Compliance Audit
Audits or audit reviews for health plans and physician organizations (reporting entities). Licensed by the National Committee for Quality assurance (NCQA) to perform HEDIS Compliance audits, our trained professionals, located throughout the United States, have extensive experience with commercial, Medicare, and Medicaid data in both health plans and provider organizations.
Hopecube.com
Hopecube.com is a site dedicated to help people with health issues find information, support, and hope. Form social networks and support groups, write daily diaries and ask health questions about a variety of problem issues.
Hospital Compare - A quality tool provided by Medicare
In this tool you will find information on how well hospitals care for patients with certain medical conditions or surgical procedures, and results from a survey of patients about the quality of care they received during a recent hospital stay. This information will help you compare the quality of care hospitals provide. Talk to your doctor about this information to help you, your family and your friends make your best hospital care decisions.
HospitalBenchmarks.com (Part of Ingenix)
View and print reports based on your specific requirements. With HospitalBenchmarks.com you have the ability to search on hospital name, hospital provider number, state, city, zip code, or a combination of any of these terms
How to Connect Patients and Physicians Around Your Brand
In this episode, Dr. Ball and Mr. LeVine discuss the importance of patient feedback — how to obtain it and how it can be used to better connect brands with patients and physicians in a practice setting.
How to Negotiate Salary
This is an often asked about and largely misunderstood topic amongst professionals at all levels. There are two critical times in everybody's career when compensation is a very important topic for discussion - when you have your performance review and when you are interviewing for a new position.
How to read articles about health and health care
By Alicia White. you need to interrogate the article to see what it says about the research it is reporting on. Bazian (the company I work for) has interrogated hundreds of articles for "Behind The Headlines" on the NHS health news Web site, and we’ve developed the following questions to help you figure out which articles you’re going to believe, and which you’re not.
How to Use an Article on Economic Analysis
Great educational tool
Humedica Forms Scientific Advisory Board
Humedica's new Scientific Advisory Board is comprised of distinguished health care informatics leaders which has produced groundbreaking research on the quality and safety of patient care, clinical outcomes, pharmacoeconomics, data standardization and exchange as well as patient privacy and security. (Source: Your-Story.org, Nov. 16, 2009)
ICD-9 Download
Include the entire text of ICD-9-CM by year, up to 2007
Identification and Retrieval of Published Health Economic Evaluation Studies
Self study education course from National Information Center on Health Services Research and Health Care Technology (NICHSR). This module describes the definition and purpose of economic evaluation studies; outlines and highlights the characteristics of the health economic evaluation literature; outlines an effective approach to identifying and retrieving economic evaluation studies from bibliographic databases; considers how economic evaluation studies are indexed in the two major bibliographic databases, MEDLINE and EMBASE
IMS Health's Price: $5.2 Billion
Two investment companies will acquire pharmaceutical database firm IMS Health for $5.2 billion, which includes assumption of $1.2 million in debt. (Source: HealthData Management, Nov. 5, 2009)
Ingenix
Coding and reimbursement products (ICD-9, CPT-4, etc.)
Institute for Medical Technology Assessment
Based in Netherlands, they are affiliated to the University of Rotterdam and research in medical technology assessment including HEOR. Till date, they have completed over 600 projects in various areas of medicine and received funding from Govt., European Commission, WHO, health care organizations, charity foundations and parma industry
Institute for Research and Information in Health Economics
A French not-for-profit organization that analyses trends in the behavior of consumers and health care professionals from a medical, economic, geographic and sociological perspective
Institute of Health Economics
IHE is a Canadian based not-for-profit organization committed to producing, gathering, and disseminating health research findings from health economics, health policy, health technology assessment and comparative effectiveness to improve the delivery of health care
Integrated Benefits Institute
News and resources related to health & productivity research and employer research.
Integrated Research Network from HealthCore
Multidimensional platform which is structured to combine aspects of traditional retrospective and prospective study designs with data obtained from physicians' offices, diagnostic laboratories and additional administrative data sets in the pursuit of "real world solutions" to clinical research and health outcomes research studies. Clinical studies span the full range of methodology from simple surveys, to registries, to complex phase 2-4 pharmacologic studies.
Iranian Health Economics Website
ISPOR Forum: Patient Registry Classification, Design, Operations, Data Analysis, Reporting & Publishing: Putting All the Pieces Together
ISPOR Patient Registry SIG
Life After Average Wholesale Price (AWP): Preparing for the Next Generation of Drug Pricing
Webinar. You can buy the recording. Recent legal action against FirstDataBank is driving industry change regarding Average Wholesale Price (AWP). Find out how new pharmacy pricing benchmarks will impact price inflation for your plan and how to respond. Plus, hear about how to achieve optimal balance of price, member cost share and utilization management for improving value and cost performance of your pharmacy benefit.
Managed Care: What
Join thought leaders in the managed care industry to hear different perspectives of the challenges ahead in the 90-minute audio conference, “Forecast: What’s Ahead for Managed Care.” Sponsored by The Executive Report on Managed Care and the Managed Care Information Center, this executive-level program was held on February 23, 2006. Cost is $227 for CD + materials
Managed Markets 2007: Pharmaceutical Reimbursement Strategy, Organizational Structure and Medicare Part D
Download or purchase Report. Benchmark your managed markets department's size and structure against those of top-tier firms, mid-size companies, and small pharmas and biotechs. Identify the structural differences and strategic business drivers that differentiate companies in each of these groups, and learn about the pitfalls that commonly affect managed markets departments at each level. Use product-specific headcounts and budgets to lobby for additional resources, and prepare your company's strategy for incorporating the Medicare Part D prescription drug benefit into structural changes, marketing planning and account management realignments.
Market Access EU Presentation, by Janice Haigh
This is a presentation by Janice Haigh at Market Access Europe 2010 that took place March 2-3, 2010.
MCP Format Version 3 and related documents
he AMCP Format for Formulary Submissions is a set of guidelines, a template that drug companies can use to prepare submissions of new and existing pharmaceuticals for a health system's Pharmacy and Therapeutics (P&T) Committee. Previously, P&T Committees often received drug information passively from pharmaceutical manufacturers that was biased and of poor quality. In this era of dramatically increasing drug costs, biotechnology, and information availability, the Format empowers health systems to pro-actively request specific information from manufacturers that will allow them to more accurately determine the total value that a drug brings to their population as the basis for accepting or rejecting a drug for its formulary.
Medical Episode Grouper
Medical Episode Grouper (MEG) uses risk-adjusted, disease-based methodology to allow users to group patients by clinically defined levels of severity and compare physicians while improving the overall quality of care. From Medstat
Medical Schools Quizzed on Ghostwriting
Senator Charles E. Grassley wrote to 10 top medical schools Tuesday to ask what they are doing about professors who put their names on ghostwritten articles in medical journals — and why that practice was any different from plagiarism by students.(Source: NYT, Nov. 17.2009)
Medicalconferences.com
A huge database of medical conferences with over 7000 upcoming events, in over 90 countries, listed. Healthcare professionals can plan their continuing education or marketing strategy by searching the database free of charge for the conference most suited to their educational needs by keywords, topics, location and date. They can even register on-line for many conferences!
MedicalMnemonics.com
You all probably remember On Old Olympus' Towering Top...well, this database has one for EVERYTHING!!! A free online searchable database of medical mnemonics to help students of health-related professions remember the important details.
Medicare 2007 Outpatient Coding and Reimbursement Final Rule Changes
oin Healthcare Reimbursement Monitor and the reimbursement experts of BESLER Consulting, a leading advisory firm in healthcare financial management and operations, to get a better understanding of the new Medicare coding and reimbursement changes for OPPS and how it will impact your organization. This live 90-minute audio conference happened on December 7, 2006. Cost is $227 for CD+materials
Medicare HMO Home Page
Oriented toward consumers, but educational.
MedicareNewsWatch.com
MediLexicon.com
A dictionary of over 200,000 medical, pharmaceutical, biomedical & healthcare acronyms and abbreviations. Plus medical news and searches for the medical, pharmaceutical or healthcare professional.
MedJournal Clinical Trial Reports Ignore Risks
An editorial in response to a new study showing how authors in major medical journals often ignore risk information when reporting clinical trial results. (Source: Ionannidis, Archives of Internal Medicine, Oct27, 2009)
Medsite.com
Services include online detailing, medical education, and market research.
Medstat Ascent®
Addresses revenue cycle challenges across a facility's functional areas and provides a reimbursement calculator, denial event triggering technology, alert systems to monitor patient accounts, and managed care contract modeling capabilities.
Medstat Core Measures
Delivers timely, efficient, and cost-effective reporting to JCAHO, CMS, and other data aggregators.
Medstat Market Expert®
Internet-based strategic planning and marketing solution that delivers detailed market analyses and projections to help you make better business decisions.
MEPSnet: Interactive statistical tool
Developed to provide immediate access to data from the Medical Expenditure Panel Survey (MEPS) in a nonprogramming environment. Available online, MEPSnet is quick and easy to use, allowing even novice users the ability to generate national estimates in a few seconds.
Mergers and Acquisitions in the Managed Care Industry: The Trends, Issues and Impact
Hear from speakers at three leading investment banking companies that focus on merger & acquisition services in the healthcare industry for both providers and payors to learn the current trends in M&A’s, what are the issues, what are state officials' issues, what acquirers are seeking in a suitable fit, the strategic buyer's interests, and, finally, the impact on providers in a consolidated market.
Methdological Issues in Conducting PE Evaluations in Clinical Trials
Advisory Panel Report from ISPOR
Modeling Guidelines from ISPOR Task Force
Excellent review of the literature, good research practices, etc. in pdf file.
Models that Decrease Hospitalization and Improve Outcomes for Medicare Beneficiaries with Chronic Illnesses
A report commissioned by the National Coalition on Care Coordination by Randall Brown, PhD, Mathematica Policy Research, March 2009
Mortality Measurement
There is increasing interest in deploying and publicly reporting a risk-adjusted measure of mortality as a quality indicator of hospital system-level performance. The presentations provided here are from a November 2008 meeting to discuss relative merits, interpretation, attributes, and potential uses related to mortality measures.
National Directory of Healthcare Payors and Providers (for YOUR state)
From Health Resources Online, you get a CD in PDF format with state-specific directories for National Directory of Managed Care Organiations, National Directory of Health Systems, Hospitals and Their Affiliates, National Directory of Physician Organizations. You can buy for just one state. Cost is $285/state.
National Directory of Managed Care Organizations,
most comprehensive and thorough directory available today. The more than 700-page directory includes market intelligence information on more than 1,500 managed care organizations, representing 5,279 managed care plans. The directory is indexed eight ways for your ease of use, to make it easy to find just what you need. Click here to order for $350
National Managed Care Roundtable
Provides innovative, informational interchange programs to address the business and clinical issues of medical directors and pharmacy directors from health plans, pharmacy benefit management companies and physician groups. Typical sponsors include pharmaceutical companies, medical device, disease management and other companies offering products and services of interest to our advisors.
New Report Shows Consumer Health Informatics Applications Can Improve Health Care Outcomes
A new Web page on consumer health information technology (health IT) applications is now available on AHRQ. (Source AHRQ, Nov 2009)
NEW REPORT: Latin American Pharmaceutical Market Outlook To 2014: Policy environment, market analysis, forecasts and growth opportunities
For more information on the cost/ content of this report contact Daniel Healy on 0044 207 551 9563 or dhealy@globalbusinessinsights.com
New Study Shows Healthcare Costs Put U.S. Workers At Big Disadvantage
The costs and performance of the U.S. healthcare system have put America’s companies and workers at a significant competitive disadvantage in the global marketplace, according to a study by the Business Roundtable. (Source: Business Roundtable.org)
New York Times Article: "Employers Offer Free Drugs to Save Costs"
Published on 2/21/07, it describes the move by several employers to offer free drugs to improve employees functioning and reduce long-term costs. Mentions several companies involved in this progressive benefit management. Good if you are involved in employer research.
NHLBI Funds Research and Training Centers Aimed at Prevention and Treatment of Chronic Diseases in Developing Countries and Collaborates with UnitedHealth Group's Chronic Disease Initiative
NHLBI Funds $34M for research and training Centers aimed at prevention and treatment of chronic diseases in developing countries and collaborates with UnitedHealth Group's Chronic Disease Initiative. Countries include Bangladesh, China, India, Argentina, Peru, and South Africa. UHC also funding research in Tunisia, Finland, and Mexico.
NYT Article: Small Gifts Found to Influence Doctors
Evidently, alot of physicians need to read Schachter's book because "small gifts are found to influence doctors" (NYT article on study in Archives of Internal Medicine).
NYT Article: What if Patient's Preference is in Conflict with Recommendations Grounded in Evidence-Based Medicine?
An interview with Dr. Berwick, a Harvard pediatrician and president for the Institute for Healthcare Improvement, about mandatory shared (between physician and patient) decision-making. Very interesting conundrum.
OASIS
OASIS- Online Analytical Statistical Information System of the Georgia Division of Public Health. A web based tool for Public Health and public policy analysis. The site includes many sources of relevant content, mapping to census tract level and demographic profiling.
Observational Research Survey Results: Spring 2009
Results from survey conducted by J Trotter Research & Consulting on issues related to observational and registry research. Download PDF of preliminary results.
Oncology Index for Managed Care
The Zitter Group’s new Managed Care Oncology Index focuses on both payers and oncology practices, making it the most comprehensive and up-to-date analysis of the major trends underway in the evolving payer market for oncology. This unique study offers pharmaceutical marketers insight into trends in physician reimbursement, product selection, practice profitability, patient access, and how managed care organizations plan to pursue oncology cost-cutting.
Oncology Market Access U.S.
Oncology Market access U.S., Seventh Edition provides leading-edge research and analysis on critical reimbursement, pricing, and competitive issues affecting the cancer drug market in the United States. This annual subscription includes direct access to our cancer marketing analytics team as well as ongoing live briefings covering the most pressing issues for manufacturers of oncology drugs. From KantarHealth.
Outcomes Research Fact Sheet from AHRQ
Great short primer for students, educators, and media personnel.
Outlook for Managed Care 2008
Growth/profitability projects, enrollment trends, premium outlook, speciality outlook, impact of universal healthcare proposals on MCO, predictions, etc.
P&T Perspective from The Zitter Group
The Zitter Group’s new simulated P&T meeting, P&T Perspective, offers pharmaceutical marketers objective and realistic insight into how their product will fare in a health plan P&T review. Unlike traditional Pharma sponsored mock P&T meetings, the composition and management of P&T Perspective closely mirrors the way that committees operate in the real world. The program uses Web-streaming technology to enable sponsors to watch the meeting anonymously, eliminating the bias inherent in a sponsored advisory board.
P4P and Public Reporting Help Quality Improvements
Hospitals engaged in both public reporting and pay-for-performance achieved modestly greater improvements in quality than did hospitals engaged in only public reporting, according to a study appearing in the New England Journal of Medicine.
Patient Insights
Market segmentation tool designed to help direct-to-customer brand teams profile and attract new customers. It identifies media and lifestyle preferences for patients with clinical profiles matching your product.
Patient Safety Expert
Medstat Patient Safety Expert® offers an end-to-end solution that maximizes the power of a patient safety program comprising an easy-to-use event recorder, workflow and reporting capabilities, and root cause analysis functionality.
Pay for Performance: Lessons Learned
CD Rom + materials from a discussion of past successes and the challenges ahead in the 90-minute audio conference, “Pay-For-Performance: Lessons Learned and Future Predictions.” This executive-level program took place on March 29, 2007. Cost is $247
Payer Perspectives on Comparative Effectiveness
Xcenda’s newest report: Payer Perspectives on Comparative Effectiveness. In addition to a historical overview of CE and in-depth coverage of its current use, the report describes how CE will impact manufacturers and other stakeholders and includes a special section focused on implications for Oncology. The report also delivers key insights into the payer perspective on CE research methods and data sources. View a glimpse of the insights contained in this new report: Comparative Effectiveness: “Rational vs. Rationing” -- Payer and Physician Perspectives on How CE will Change US Healthcare
Payer Perspectives on Comparative Effectiveness
Xcenda’s newest report uncovers Payer Perspectives on Comparative Effectiveness. In addition to a historical overview of CE and in-depth coverage of its current use, the report describes how CE will impact manufacturers and other stakeholders and includes a special section focused on implications for Oncology. The report also delivers key insights into the payer perspective on CE research methods and data sources. View a glimpse of the insights contained in this new report: Comparative Effectiveness: “Rational vs. Rationing” -- Payer and Physician Perspectives on How CE will Change US Healthcare
Pfizer to develop online community to find new trials patients
Pfizer to develop online community to find new trials patients. Pfizer is hoping to unlock the power of online communities to help it recruit more people for clinical trials. (Source: PharmaFocus, Aug. 24, 2009)
Pharma Marketing Blog
Blog from John Mack, publisher ofPharma Marketing News, a monthly e-newsletter
Pharma Marketing Blog: It's a Bird, It's a Plane, It's Pharmexec 50, but what's that molecule?
Does anyone create and follow a target product profile? PharmExec.Com calls it the "Holy Grail of Product Development". Speaking of PharmExec.Com, look at their version of technology gone wild. Love it or hate it? Here's what John Mack of PharmaMktg Blog has to say.
Pharmaceutical Industry at Crossroads
Pharmaceutical Industry at Crossroads Experts suggest innovate, collaborate, or merge. (Source: Heide B. Malhotra, The Epoch Times, July 7, 2009)
Pharmaceutical Industry Info
List of Pharmaceutical Companies / Suppliers and Projects, Press Releases, News and Resources in our Directory.
Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies
Proprietary report published November 2007 by Business Insights. Cost $ 2,875.00
Pharmaceutical Pricing: Analysis of Resources, Strategy and Structure.
Download a PDF. This report analyzes the practices of some of the industry’s top pricing departments to provide the steps pricing managers must take to make their functions more integral pieces of the development puzzle. The report provides pricing leaders the tools to improve their pricing departments by comparing their spending, staffing, structure and strategies to those of top pharmaceutical companies.
Pharmacoeconomic Guidelines Around the World
Great resource from ISPOR. Country-specific guidelines’ key features (32) as well as hyperlinks or full text of the guideline (as copyright permission allows) or publication reference including a map of the country
Pharmacoeconomics to Get Bigger Budgets, According to Preliminary Survey Results
This year, drug makers' pharmacoeconomics groups will spend more money than ever before -- a clear sign of the function's growing importance to success in the pharmaceutical and biotechnology sectors. (Source: Marketwire, 2/15/2010)
Pharmacoeconomics: Identifying the Issues
Publication from ISPOR covering issues to consider in CEA/QOL within clinical trials, modeling, patient reported outcomes, claims analysis, etc. Good educational tool
PharmacoEthics
Dedicated to the exploration of ethical issues related to the development, promotion, sales, prescription, and use of pharmaceuticals.
Pharmalicensing.com
This knowledge packed resource, contains pipeline, financial, analytics, competitor, and partnering information on up to 10,000 biomedical companies worldwide.
PharmaModel from Alliance
Patient-based and disease-specific market model,intuitive and easy to update, maintain or refine on an ongoing basis and can be used on a national, regional or international level. It accommodates up to 52 ountries, with country-specific data gathering possibilities, allowing free inputs for data gaps. Impacts of any market update and any epidemiologic, treatment or label changes are immediately accounted for.
Pharmerging shake-up
More than three years have passed since IMS Health first coined the term “pharmerging market” in recognition of the major shift in growth away from the mature, developed economies to the seven fast-growing emerging economies of China, Brazil, Russia, India, Mexico,Turkey, and South Korea. (Source: IMS Market Prognosis, 2006-2010)
Pharmfocus: Coast first casualty in US overhaul of IRB system
Sting operation closing doors of some IRB offices. What do you know about your IRB?
Podcast: Better Standards and Performance Metrics for Clinical Trials
What if every baseball team used different methods to track RBIs, speed of pitched balls, and league standings? Well, that's what is going on in the CRO industry. Learn more about the push to improve this situation by listening to the FREE podcast: "Better Standards and Performance Metrics for Clinical Trials". Sponsored by i3 StatProbe.
Podcast: Changing Relationship Between CRO's and Drug Developers
"Changing Relationship Between CROs and Drug Developers", a podcast from PharmaVoice including trends, how to maximize relationship, and metric tracking.
Power and Sample Size Calculator
Runs on Windows; produces graphs to explore relationship between power, sample size, and detectable alternative hypotheses. GREAT TOOL.
Predictors of Enrollment in Medicare Part D: Are Benificiaries Rational?
Powerpoint Presentation by Lisa Lines, MPH, of Boston Health Economics given at ISPOR 2009.
Presentation: Global Health Care Reimbursement Systems and Decision Processes Working Group of the ISPOR HTA SIG Forum: Health Care Decision Makers around the World: A Global Road Map and Country–specific Decision-Making and Reimbursement Processes
Click to see PPT Presentation
Presentation: ISPOR Conjoint Analysis in Health Task Force Forum: A Checklist for Good Research Practices for the Application of Conjoint Analysis in Health
Click to view PPT Presentation
Presentation: ISPOR Good Research Practices for the Retrospective Database Studies Task Force Forum: Good Research Practices on the Design And Analysis Of Non-Randomized Studies Of Treatment Effects Using Secondary Databases
Click to see PPT Presentation
Presentation: ISPOR Health & Disease Management SIG Forum: Reliability & Validity of Data Sources for Health & Disease Management: Rationality in an Era of Controversy
Click to see PPT Presentation
Presentation: ISPOR Health Science Policy Council Forum: Update on Comparative Effectiveness and Health Information Technology Legislation and Policy Developments, and Their Impact on Pharmacoeconomics
Click to see PPT Presentation
Presentation: ISPOR HTA Council & SIG Forum: Reimbursement Policy Decision making Process in the US: Private versus Public
Click to see PPT Presentation
Presentation: ISPOR Medication Compliance & Persistence SIG Forum: Assessment, Determinants & Economics of Medication Compliance & Persistence
Click to see PPT Presentation
Presentation: ISPOR Patient Registry SIG Forum: Patient Registry Design, Operations, Data Analysis, Reporting & Publishing: Putting All the Pieces Together
Click to see PPT Presentation
Presentation: ISPOR PRO Existing Instruments & Their Modification Task Force Forum: Good Research Practices on Evaluating and Documenting the Content Validity of PRO Instruments to Support Medical Product Labeling
Click to see PPT Presentation
Presentation: ISPOR Quality Improvement in Cost Effectiveness Research Task Force Forum: Quality Improvement In Cost Effectiveness Research
Click to see PPT Presentation
Presentation: ISPOR Risk Management SIG Forum: Risk Benefit Management
Click to see PPT Presentation
PriceWaterhouse Pharma2020: The Vision
Trends and forecasting report on the status of the pharma industry for the next decade.
Pricing, market access and the return of reality
Except when they are distorted by legislation or market imperfections, markets set the price of products and services based on their value to the consumer. Certainly, short-term digressions and knowledge anisotropy create temporary opportunities, but in the long run, and especially in this information age, suppliers should expect to get a price that reflects the value of what they provide.
Primer on Outcomes Research
Download PDF or HTML. From Foundation for Health Services Research. Primer PDF is available at: http://www.healtheconomics.com/admin/addAsite.cfm
Privacy Survey -- In Providers We Trust
Ponemon Institute published their study surveying American opinions on privacy of their health information. They found: 71% of Americans trust their providers with their medical information much more than they trust payers (43%), state and local government (31%), private information technology companies (27%) or the federal government (27%). (Source: Health Care Technology News, Feb. 1, 2010)
Product Approvals: FDA
Monthly listing.
QALYs: Will they survive
ISPOR QALY Consensus Development Workshop Building a Pragmatic Road: An ISPOR Development Workshop on Moving the QALY Forward (By Invitation Only) November 7–8, 2007 Philadelphia, Pennsylvania, USA
Quality Improvement in Pharmacoeconomic Evaluations
Link to results of an ISPOR Task Force. This link includes a GREAT table from Mike Drummond entitled "Detecting Flaws in Economic Evaluation". GREAT resource for students
Registries and AHRQ requirements
Listen to MP3 of how patient registries assist AHRQ with quality assessment.
Reimbursement Briefing: New FY 2010 Medicare Inpatient Prospective Payment System (IPPS) Final Rule -- What Your Hospital Needs to Know
90-Minute Audio Webcast on CD-Rom; fees apply. (Source: Health Resources Online)
Retrospective Claims Analysis Issues to Consider
Advisory Panel Report from ISPOR
Sales Force of the Future
This article presents ideas of various experts on influences on the "Sales Force of the Future". (Source: Robin Robinson, PharmaVOICE, Nov/Dec. 2009)
Sample Size Analysis: UnifyPow
Free download from SAS
Sermo Launches the Practice Management Exchange to Support the New Physician Practice in a Changing Healthcare World
Sermo, the nation's largest online physician community, today (11/5/09) introduced the Practice Management Exchange (PME), a new social media offering that brings physicians together from across the country to exchange business advice, earn CME credits on practice management topics, and provide quality patient care in a system that desperately needs reform. (Source: Reuters)
SERMO: Online Physician Community
Physicians around the nation exchange the latest medical insights with each other and improve patient outcomes - 24/7. Used for epidemiology, patient outcomes, surveys, etc.
Simulation sample sizes for Monte Carlo partial EVPI calculations
Published in J Health Economics. Partial expected value of perfect information (EVPI) quantifies the value of removing uncertainty about unknown parameters in a decision model. EVPIs can be computed via Monte Carlo methods. An outer loop samples values of the parameters of interest, and an inner loop samples the remaining parameters from their conditional distribution. This nested Monte Carlo approach can result in biased estimates if small numbers of inner samples are used and can require a large number of model runs for accurate partial EVPI estimates.
Simulation sample sizes for Monte Carlo partial EVPI calculations
PDF by Oakley et al. Partial expected value of perfect information (EVPI) quantifies the value of removing uncertainty about unknown parameters in a decision model. EVPIs can be computed via Monte Carlo methods. This nested Monte Carlo approach can result in biased estimates if small numbers of inner samples are used and can require a large number of model runs for accurate partial EVPI estimates.
Skills needed to conduct Econ evaluations
Advisory Panel Report from ISPOR
Sources and Characteristics of Information Relating to Health Care Financing in the US
Self study education course from National Information Center on Health Services Research and Health Care Technology (NICHSR). Goals of module include: 1) the significant trends in spending, outcomes, and access within the U.S. health care system; and; 2)the main sources of literature and data relating to health care financing in the U.S.
Spending by Consumers on Health Care: A Data Brief
Prepared for Congress December 2007.
Spending on new drug development
Updates annual drug development expenditures. Average expenditure on drugs in human clinical trials is around $27m per year, with $17m per year on drugs in Phase I, $34m on drugs in Phase II and $27m per year on drugs in Phase III of the human clinical trials. (Source: Christopher Paul Adams and Van Vu Brantner, Health Economics, Feb. 26 2009)
Spotty Reporting of Adverse Events Noted in Big-Name Journals
Many clinical trial reports were missing clear analyses of drug side effects. (Source: John Gever, MedPage Today, 2009)
Standardizing Quality Assessment of Observational Studies for Decision Making in Health Care
Report from Roundtable of managed care experts and pharmacoeconomists on "Overcoming Barriers to Incorporating Real-World Data into Healthcare Decision-making" is summarized in recent article by Brixner et al. in Journal of Managed Care Pharmacy. Includes key recommendations. Fairman and Curtis follow with an editorial on challenges of editing these types of studies for JMCP. If you do research with these type of data, this is a must-read.
Statistics.Com
Statistics Tutoring Service is a great service. Get help in introductory statistics. Simply submit your query online by 11pm Est Sunday - Thursday and in most cases you will have an answer by the next morning.leading provider of professional development courses in statistics.
Statistics: Number needed to treat
Graphic showing number needed to treat to get a benefit for various drugs
Statpages.net
Best supply of free stats programs you'll ever find.
Stats Calculator
To calculate Sensitivity, Specificity, NPV, Relative Risk, Absolute Risk, Number Needed to Treat, Odds Ratio, Relative Risk Reduction, Absolute Risk Reduction,
StatsDirect Statistical Software
This downloadable statistics package can be placed on a local machine and then used to calculate odds ratios, relative risk and other clinical measures such as Numbers Needed to Treat. It includes exact confidence intervals for all of these which is very rare.
Summary Health IT Portfolio as of 2008
AHRQ releases Summary Health IT Portfolio 2008, an overview of nearly 150 summaries by strategic and business goals, project milestones, and other characteristics (Source: AHRQ, October 2009)
Take the lead on late-phase studies, urges Quintiles executive
Pharma Co's must "get a grip" on late-phase research, or other groups (e.g., payers, FDA) will do it for you, and decisions will be based on price! The article cites the recent head-to-head clinical trial of the blood thinners Plavix (clopidogrel, Bristol-Myers Squibb/Sanofi Aventis) and Effient (prasugrel, Eli Lilly/Daiichi Sankyo) conducted by Medco. (Source: PharmaTimes, Dec. 9, 2009)
The CEA Registry Blog
Welcome to the CEA Registry Blog by the Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA. We have developed this blog to encourage interactivity among our users by allowing readers to post comments and questions about the Registry. The forum of this blog ranges from posting brief online updates to more in-depth content, enabling our users to be in-the-know about new developments and resources. We invite all comments and suggestions.
The Cost of Inaction: The Urgent Need for Health Reform
Excellent report containing great metrics and trends on health care costs in "The Cost of Inaction: the Urgent Need for Health Reform"
The Dartmouth Atlas of Health Care
Provides data on regional costs and spending for healthcare. Website provides access to all Atlas reports and publications, as well as interactive tools to allow visitors to view specific regions and perform their own comparisons and analyses.
The Data Management & Analysis Working Group's article, Analysis of Effectiveness in Patient Registry Data is published in the Policy Analysis section of the June issue of ISPOR CONNECTIONS.
Click to see presentation
The End of Free Drug Pricing in Germany?
Germany's health minister Philipp Roesler may open fire against the branded drug industry with a proposal to break the sector's so-called 'price monopoly' and force them to negotiate lower prices directly with insurers. (Source: InVivio Blog, March 08, 2010)
The End of Free Drug Pricing in Germany?
According to local press, Germany's health minister Philipp Roesler is about to open fire against the branded drug industry with a proposal to break the sector's so-called 'price monopoly' and force them to negotiate lower prices directly with insurers. Until now, Germany has been one of Europe's last bastions of "free" upfront drug pricing. Sure, the hurdles come afterwards, but both there and in the UK drug firms have--until now--been allowed to set more or less the price they like for new drugs. (Source: The IN VIVO Blog, March 8, 2010)
The Full Costs of Depression in the Workforce
IBI Releases Full Costs of Depression Research Report and Survey. Includes excellent slide deck. IBI research shows that a full-cost view of depression's workforce effects presents unanticipated employer costs and significant challenges. To help employers use the research findings, IBI member experts suggest how to overcome challenges identified in the research. Based on 400K+ claims from Ingenix plus Healht and Work Performance Questionnaire.
The Future Costs, Risks and Rewards of Drug Development: The Economics of Pharmacogenomics
A new study funded by the National Pharmaceutical Council (NPC) shows that pharmacogenomics -- the field of scientific research focused on learning how genetic profiles predict the body's response to medicines - has the potential to lead to higher levels of research and development (R&D) investment and an increased pace of pharmaceutical innovation, offering substantial benefits for patients. (Source: PharmacoEconomics, Volume 27, Number 5, 5 May 2009 , pp. 355-363(9))
The Future of Health Technology Assessment in Healthcare Decision Making in Asia
The report addresses use of HTA (Health Technology Assessment) in establishing health care policy in Asia. (source: AdisOnline, PharmacoEconomics: 1 November 2009 - Volume 27 - Issue 11 - pp 891-901)
The Growing Importance of Health Technology Assessments (HTAs) in
There are now over 40 national agencies globally, each with its own standards and procedures for HTA evaluation, but evaluation methods vary and are continuously changing. In order to understand the landscape for HTAs across the world, United BioSource Corporation (UBC) conducted a review of HTA requirements in10 markets. (Source: United BioSource Corporation Evidence Matters Newsletter, March 2010).
The Health Care Status Quo
HHS State Report has recently been issued, including statistics on health care cost and quality for each of the 50 states in US. Examples include % increase in health premiums, costs of care for uninsured, % of state residents without health insurance, and quality ratings.
The Health Economics Blog: Trends, Politics, Opinions in the Pharma/Biotech Industry
Blogging by Ulf Stagginus. Click here to read. Great topics, take time to respond!
The Managed Care Injectables Index
From The Zitter Group, published twice a year. This link takes you to Zitter's website to gain more info on the syndicated bi-annual report.
The New Four P's of Marketing
Remember the 4-P's of Marketing (product, placement, price, and promotion)? PharmExec.Com suggests these have been replaced by 4 New P's: Predictive Modeling, Personalization, Peer-to-Peer, Participation. According to the author, " Merely driving demand doesn't work anymore. The key to success in this new marketing landscape is a shift from a pharmaceutical-driven, push-based model toward a pull-based model, where desire for information and education drives action on the part of consumers and medical professionals." (Source: John Gardner, PharmaExec, Dec. 9, 2009)
The New Yorker Article: The Cost Conundrum
"Providing health care is like building a house. The task requires experts, expensive equipment and materials, and a huge amount of coördination. Imagine that, instead of paying a contractor to pull a team together and keep them on track, you paid an electrician for every outlet he recommends, a plumber for every faucet, and a carpenter for every cabinet. Would you be surprised if you got a house with a thousand outlets, faucets, and cabinets, at three times the cost you expected, and the whole thing fell apart a couple of years later?"
The Pharmacoeconomics Outlook: Turning Value-For-Money Requirements Into A Competitive Advantage
Management report that assesses the impact that pharmacoeconomics has had on the pharmaceutical industry and shows how companies can utilize pharmacoeconomic modeling to gain a competitive edge. This report examines the most commonly used pharmacoeconomic methodologies with respect to both study perspective and the range of R&D costs that can be analyzed.
The Pharmacoeconomics Outlook: Turning value-for-money requirements into a competitive advantage (PPT Presentation)
Basic overview, regulatory issues, case studies on valuation, including NICE. (Source: Business Insights, 2003)
The Scope of Health Economics
Self study education course from National Information Center on Health Services Research and Health Care Technology (NICHSR)in 2 parts: Part 1 - outlines the scope of the subdiscipline of health economics and highlights the range of potential information required; Part 2 - outlines and highlights the type of information that may be required and key sources of that information
TV Review: The Price of Life
BBC Documentary "The Price of Life" discussed NICE and is causing much controversy.
UnitedHealthcare 'Refill and Save Program' Rewards Prescription Drug Compliance with Discounts on Select Medications
The payer offers $20 discounts off certain prescription drug co-payments for select asthma and depression medications for plan participants who refill their medications on a timely basis.(Source: Businesswire, Feb. 01, 2010)
Use of Bayesian Techniques in Randomized Clinical Trials: A CMS Case Study
Available June 25-July 10, 2009 for public comment.
Use of Real World Data: Challenges in the Analysis of Patient Registry Data
Click to see presentation
VALUE 1000 – A PRACTICAL PROPOSAL FOR MEASURING QUALITY IN HEALTHCARE
VALUE 1000 – A PRACTICAL PROPOSAL FOR MEASURING QUALITY IN HEALTHCARE: This paper explores some practical ways of measuring quality and value in healthcare. (Source: Kishore Somanathan, Meta Analytics LLC, 2009)
Voice Response System to Measure Healthcare Costs
AJMC article "Voice Response System to Measure Healthcare Costs: A STAR*D Report" by Kashner, et al.
Webcast: Optimizing Market Access: Your Guide to Effective Pricing, Reimbursement and messaging Strategies
"Optimizing Market Access: Your Guide to Effective Pricing, Reimbursement and Messaging Strategies" Webcast sponsored by: TNS Healthcare.
Webcast: New ICD-10 Coding in US
The Department of Health and Human Services (HHS) finalized its proposal to adopt the International Classification of Diseases, 10th Revision (ICD-10) coding system in the U.S. (Soruce: Covance Market Access Services, October 27, 2009)
Wellness Incentives: Beyond Mugs and T-Shirts
Explore the types of wellness incentives that work to boost participation and, most importantly, health improvement in this special 90-minute audio conference that took place on January 25, 2007. Cost is $227 for CD + materials
What
Looking for an easy way to acquaint your team with “pay-for-performance” (P4P)? Introducing the P4P Audio Conference CD Box Set. These highly rated, executive-level telebriefings on CD are ideal for low cost, affordable team training. The programs feature four early adopter insiders providing details, metrics, payment structure, characteristics of successful programs, design principles and what's working are key points covered in three hours of high-level management discussion on details on pay for performance. Each program is 90 minutes long and includes a 30-minute question and answer session. The CDs also contain visual aids. $299
White Paper: An Economic Assessment of the Relationship between Price Regulation and Incentives to Innovate in the Pharmaceutical Industry
In this paper, we explore the possible consequences that pricing and reimbursement regulation may have on pharmaceutical innovation. We first investigate qualitatively how a pharmaceutical firm is likely to strategically respond in its R&D activities to pricing and reimbursement regulation. We then quantitatively evaluate these effects in the context of a calibrated decision-theoretic model of drug development in which a pharmaceutical firm is forward-looking and takes future pricing regulation into account in making current development decisions. Source: Hans Friederiszick, ESMT CA Nicola Tosini, ESMT CA Francis de Ve´ricourt, ESMT Simon Wakeman, ESMT
WHO CHOICE (International CEA)
WHO-CHOICE reports the costs and effects of a wide range of health interventions in the 14 epidemiological sub-regions (world divisions made based on geographical location and epidemiological profiles). The results of these cost-effectiveness analysis are assembled in regional databases, which policy makers can adapt to their specific country setting.
Wikipedia on Health Economics
Good definition, examples, links
Workshop 12: A Taxonomy for the Design, Development & Implementation of Patient Registries
Click to see presentation
Workshop 9: Analysis of Effectiveness and Cost Effectiveness in Patient Registries
Click to see presentation
Wright on Health
This is a blog devoted to making matters of health policy and health services research accessible to a wide audience. The blogger, Brad Wright, is a doctoral candidate in health policy and management at UNC, and his work also appears on the Huffington Post.
X PRIZE Foundation
$10M prize, called Healthcare X Prize, is available to the individual or group who create an optimal health paradigm that empowers and engages individuals and communities in a way that dramatically improves health value. Following the recent announcement, the public is invited to comment on the approach and provide feedback to ensure that the competition results in affordable, high-quality health care for all communities.




 

Insurance Resources: Even healthy people need life insurance.
Get life insurance quotes today.

 

sponsored by






































Become a sponsor



How are we doing? Take our survey





Copyright © 2007, HealthEconomics.Com